Autopsy report · NCT01164904
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Cause of deathNo reason given
Life of this trial
- Ran for about 2 years 8 months before it stopped.
- 72 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Amgen
- Sponsor type
- Industry
- Conditions
- Ulcerative Colitis
- Interventions
- Amg 181
- Participants
- 72
- Sites
- 10
- Countries
- Australia, New Zealand, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.